Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Nikhil Munshi
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Anatomy
Living Beings
Physiology
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
121
Anderson, Kenneth
92
Hideshima, Teru
74
Chauhan, Dharminder
62
Mitsiades, Constantine
45
podar, klaus
37
Tai, Yu-Tzu
35
Mitsiades, Nicholas
34
Richardson, Paul
28
Schlossman, Robert
28
Richardson, Paul
26
Raje, Noopur
25
Catley, Laurence
25
Shammas, Masood Ahmad
23
Tassone, Pierfrancesco
17
Neri, Paola
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Nikhil Munshi (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Negri Joseph M; McMillin Douglas W; Delmore Jake; Mitsiades Nicholas; Hayden Patrick; Klippel Steffen; Hideshima Teru; Chauhan Dharminder; Munshi Nikhil C; Buser Carolyn A; Pollard John; Richardson Paul G; Anderson Kenneth C; Mitsiades Constantine S
In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465.
British journal of haematology 2009;147(5):672-6.
-
2009: Laubach Jacob P; Mitsiades Constantine S; Mahindra Anuj; Schlossman Robert L; Hideshima Teru; Chauhan Dharminder; Carreau Nicole A; Ghobrial Irene M; Raje Noopur; Munshi Nikhil C; Anderson Kenneth C; Richardson Paul G
Novel therapies in the treatment of multiple myeloma.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(9):947-60.
-
2009: Chauhan Dharminder; Singh Ajita V; Brahmandam Mohan; Carrasco Ruben; Bandi Madhavi; Hideshima Teru; Bianchi Giada; Podar Klaus; Tai Yu-Tzu; Mitsiades Constantine; Raje Noopur; Jaye David L; Kumar Shaji K; Richardson Paul; Munshi Nikhil; Anderson Kenneth C
Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target.
Cancer cell 2009;16(4):309-23.
-
2009: Blotta Simona; Tassone Pierfrancesco; Prabhala Rao H; Tagliaferri Piersandro; Cervi David; Amin Samir; Jakubikova Jana; Tai Yu-Tzu; Podar Klaus; Mitsiades Constantine S; Zullo Alessandro; Franco Brunella; Anderson Kenneth C; Munshi Nikhil C
Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance.
Blood 2009;114(15):3276-84.
-
2009: Pozzi Samantha; Vallet Sonia; Mukherjee Siddhartha; Cirstea Diana; Vaghela Nileshwari; Santo Loredana; Rosen Eyal; Ikeda Hiroshi; Okawa Yutaka; Kiziltepe Tanyel; Schoonmaker Jesse; Xie Wanling; Hideshima Teru; Weller Edie; Bouxsein Mary L; Munshi Nikhil C; Anderson Kenneth C; Raje Noopur
High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(18):5829-39.
-
2009: Avet-Loiseau Hervé; Li Cheng; Magrangeas Florence; Gouraud Wilfried; Charbonnel Catherine; Harousseau Jean-Luc; Attal Michel; Marit Gerald; Mathiot Claire; Facon Thierry; Moreau Philippe; Anderson Kenneth C; Campion Loïc; Munshi Nikhil C; Minvielle Stéphane
Prognostic significance of copy-number alterations in multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(27):4585-90.
-
2009: McMillin Douglas W; Ooi Melissa; Delmore Jake; Negri Joseph; Hayden Patrick; Mitsiades Nicolas; Jakubikova Jana; Maira Sauveur-Michel; Garcia-Echeverria Carlos; Schlossman Robert; Munshi Nikhil C; Richardson Paul G; Anderson Kenneth C; Mitsiades Constantine S
Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.
Cancer research 2009;69(14):5835-42.
-
2009: Richardson Paul G; Xie Wanling; Mitsiades Constantine; Chanan-Khan Asher A; Lonial Sagar; Hassoun Hani; Avigan David E; Oaklander Anne Louise; Kuter David J; Wen Patrick Y; Kesari Santosh; Briemberg Hannah R; Schlossman Robert L; Munshi Nikhil C; Heffner L Thompson; Doss Deborah; Esseltine Dixie-Lee; Weller Edie; Anderson Kenneth C; Amato Anthony A
Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(21):3518-25.
-
2009: Hideshima Teru; Ikeda Hiroshi; Chauhan Dharminder; Okawa Yutaka; Raje Noopur; Podar Klaus; Mitsiades Constantine; Munshi Nikhil C; Richardson Paul G; Carrasco Ruben D; Anderson Kenneth C
Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells.
Blood 2009;114(5):1046-52.
-
2009: Fulciniti Mariateresa; Tassone Pierfrancesco; Hideshima Teru; Vallet Sonia; Nanjappa Puru; Ettenberg Seth A; Shen Zhenxin; Patel Nipun; Tai Yu-Tzu; Chauhan Dharminder; Mitsiades Constantine; Prabhala Rao; Raje Noopur; Anderson Kenneth C; Stover David R; Munshi Nikhil C
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma.
Blood 2009;114(2):371-9.
-
2009: Hideshima Teru; Chauhan Dharminder; Kiziltepe Tanyel; Ikeda Hiroshi; Okawa Yutaka; Podar Klaus; Raje Noopur; Protopopov Alexei; Munshi Nikhil C; Richardson Paul G; Carrasco Ruben D; Anderson Kenneth C
Biologic sequelae of I{kappa}B kinase (IKK) inhibition in multiple myeloma: therapeutic implications.
Blood 2009;113(21):5228-36.
-
2009: Mitsiades Constantine S; Hideshima Teru; Chauhan Dharminder; McMillin Douglas W; Klippel Steffen; Laubach Jacob P; Munshi Nikhil C; Anderson Kenneth C; Richardson Paul G
Emerging treatments for multiple myeloma: beyond immunomodulatory drugs and bortezomib.
Seminars in hematology 2009;46(2):166-75.
-
2009: Tai Yu-Tzu; Soydan Ender; Song Weihua; Fulciniti Mariateresa; Kim Kihyun; Hong Fangxin; Li Xian-Feng; Burger Peter; Rumizen Matthew J; Nahar Sabikun; Podar Klaus; Hideshima Teru; Munshi Nikhil C; Tonon Giovanni; Carrasco Ruben D; Afar Daniel E H; Anderson Kenneth C
CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf-mediated interactions with bone marrow stromal cells.
Blood 2009;113(18):4309-18.
-
2009: Azab Abdel Kareem; Runnels Judith M; Pitsillides Costas; Moreau Anne-Sophie; Azab Feda; Leleu Xavier; Jia Xiaoying; Wright Renee; Ospina Beatriz; Carlson Alicia L; Alt Clemens; Burwick Nicholas; Roccaro Aldo M; Ngo Hai T; Farag Mena; Melhem Molly R; Sacco Antonio; Munshi Nikhil C; Hideshima Teru; Rollins Barrett J; Anderson Kenneth C; Kung Andrew L; Lin Charles P; Ghobrial Irene M
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.
Blood 2009;113(18):4341-51.
-
2009: Shammas Masood A; Shmookler Reis Robert J; Koley Hemanta; Batchu Ramesh B; Li Cheng; Munshi Nikhil C
Dysfunctional homologous recombination mediates genomic instability and progression in myeloma.
Blood 2009;113(10):2290-7.
-
2009: Raab Marc S; Breitkreutz Iris; Tonon Giovanni; Zhang Jing; Hayden Patrick J; Nguyen Thu; Fruehauf Johannes H; Lin Boris K; Chauhan Dharminder; Hideshima Teru; Munshi Nikhil C; Anderson Kenneth C; Podar Klaus
Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signaling.
Blood 2009;113(7):1513-21.
-
2009: Treon Steven P; Soumerai Jacob D; Branagan Andrew R; Hunter Zachary R; Patterson Christopher J; Ioakimidis Leukothea; Chu Luis; Musto Paul; Baron Ari D; Nunnink Johannes C; Kash Joseph J; Terjanian Terenig O; Hyman Paul M; Nawfel Elena L; Sharon David J; Munshi Nikhil C; Anderson Kenneth C
Lenalidomide and rituximab in Waldenstrom's macroglobulinemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(1):355-60.
-
2008: Ho Allen W; Hatjiharissi Evdoxia; Ciccarelli Bryan T; Branagan Andrew R; Hunter Zachary R; Leleu Xavier; Tournilhac Olivier; Xu Lian; O'Connor Kelly; Manning Robert J; Santos Daniel Ditzel; Chemaly Mariana; Patterson Christopher J; Soumerai Jacob D; Munshi Nikhil C; McEarchern Julie A; Law Che-Leung; Grewal Iqbal S; Treon Steven P
CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia.
Blood 2008;112(12):4683-9.
-
2008: Neri Paola; Tagliaferri Pierosandro; Di Martino Maria Teresa; Calimeri Teresa; Amodio Nicola; Bulotta Alessandra; Ventura Monica; Eramo Pasqua Orietta; Viscomi Caterina; Arbitrio Mariamena; Rossi Marco; Caraglia Michele; Munshi Nikhil C; Anderson Kenneth C; Tassone Pierfrancesco
In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
British journal of haematology 2008;143(4):520-31.
-
2008: Song Weihua; van der Vliet Hans J J; Tai Yu-Tzu; Prabhala Rao; Wang Ruojie; Podar Klaus; Catley Laurence; Shammas Masood A; Anderson Kenneth C; Balk Steven P; Exley Mark A; Munshi Nikhil C
Generation of antitumor invariant natural killer T cell lines in multiple myeloma and promotion of their functions via lenalidomide: a strategy for immunotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(21):6955-62.
-
2008: Shammas Masood A; Qazi Aamer; Batchu Ramesh B; Bertheau Robert C; Wong Jason Y Y; Rao Manjula Y; Prasad Madhu; Chanda Diptiman; Ponnazhagan Selvarangan; Anderson Kenneth C; Steffes Christopher P; Munshi Nikhil C; De Vivo Immaculata; Beer David G; Gryaznov Sergei; Weaver Donald W; Goyal Raj K
Telomere maintenance in laser capture microdissection-purified Barrett's adenocarcinoma cells and effect of telomerase inhibition in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(15):4971-80.
-
2008: Tai Yu-Tzu; Dillon Myles; Song Weihua; Leiba Merav; Li Xian-Feng; Burger Peter; Lee Alfred I; Podar Klaus; Hideshima Teru; Rice Audie G; van Abbema Anne; Jesaitis Lynne; Caras Ingrid; Law Debbie; Weller Edie; Xie Wanling; Richardson Paul; Munshi Nikhil C; Mathiot Claire; Avet-Loiseau Hervé; Afar Daniel E H; Anderson Kenneth C
Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu.
Blood 2008;112(4):1329-37.
-
2008: Mitsiades Constantine S; Ocio Enrique M; Pandiella Atanasio; Maiso Patricia; Gajate Consuelo; Garayoa Mercedes; Vilanova David; Montero Juan Carlos; Mitsiades Nicholas; McMullan Ciaran J; Munshi Nikhil C; Hideshima Teru; Chauhan Dharminder; Aviles Pablo; Otero Gabriel; Faircloth Glynn; Mateos M Victoria; Richardson Paul G; Mollinedo Faustino; San-Miguel Jesus F; Anderson Kenneth C
Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivo.
Cancer research 2008;68(13):5216-25.
-
2008: Richardson Paul G; Mitsiades Constantine; Schlossman Robert; Ghobrial Irene; Hideshima Teru; Munshi Nikhil; Anderson Kenneth C
Bortezomib in the front-line treatment of multiple myeloma.
Expert review of anticancer therapy 2008;8(7):1053-72.
-
2008: Munshi Nikhil C; Mitsiades Constantine; Richardson Paul G; Anderson Kenneth C
Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma.
Nature clinical practice. Oncology 2008;5(7):374-5.
-
2008: Shammas M A; Koley H; Bertheau R C; Neri P; Fulciniti M; Tassone P; Blotta S; Protopopov A; Mitsiades C; Batchu R B; Anderson K C; Chin A; Gryaznov S; Munshi N C
Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(7):1410-8.
-
2008: Wong Jason Y Y; Huggins Gordon S; Debidda Marcella; Munshi Nikhil C; De Vivo Immaculata
Dichloroacetate induces apoptosis in endometrial cancer cells.
Gynecologic oncology 2008;109(3):394-402.
-
2008: Ishitsuka Kenji; Hideshima Teru; Neri Paola; Vallet Sonia; Shiraishi Norihiko; Okawa Yutaka; Shen Zhenxin; Raje Noopur; Kiziltepe Tanyel; Ocio Enrique M; Chauhan Dharminder; Tassone Pierfrancesco; Munshi Nikhil; Campbell Robert M; Dios Alfonso De; Shih Chuan; Starling James J; Tamura Kazuo; Anderson Kenneth C
p38 mitogen-activated protein kinase inhibitor LY2228820 enhances bortezomib-induced cytotoxicity and inhibits osteoclastogenesis in multiple myeloma; therapeutic implications.
British journal of haematology 2008;141(5):598-606.
-
2008: Munshi Nikhil C; Digumarthy Subba; Rahemtullah Aliyah
Case records of the Massachusetts General Hospital. Case 13-2008. A 46-year-old man with rheumatoid arthritis and lymphadenopathy.
The New England journal of medicine 2008;358(17):1838-48.
-
2008: Raje Noopur; Woo Sook-Bin; Hande Karen; Yap Jeffrey T; Richardson Paul G; Vallet Sonia; Treister Nathaniel; Hideshima Teru; Sheehy Niall; Chhetri Shweta; Connell Brendan; Xie Wanling; Tai Yu-Tzu; Szot-Barnes Agnieszka; Tian Mei; Schlossman Robert L; Weller Edie; Munshi Nikhil C; Van Den Abbeele Annick D; Anderson Kenneth C
Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(8):2387-95.
-
2008: Huston Alissa; Leleu Xavier; Jia Xiaoying; Moreau Anne-Sophie; Ngo Hai T; Runnels Judith; Anderson Judy; Alsayed Yazan; Roccaro Aldo; Vallet Sonia; Hatjiharissi Evdoxia; Tai Yu-Tsu; Sportelli Peter; Munshi Nikhil; Richardson Paul; Hideshima Teru; Roodman David G; Anderson Kenneth C; Ghobrial Irene M
Targeting Akt and heat shock protein 90 produces synergistic multiple myeloma cell cytotoxicity in the bone marrow microenvironment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(3):865-74.
-
2008: Chauhan Dharminder; Singh Ajita; Brahmandam Mohan; Podar Klaus; Hideshima Teru; Richardson Paul; Munshi Nikhil; Palladino Michael A; Anderson Kenneth C
Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma.
Blood 2008;111(3):1654-64.
-
2008: Jinushi Masahisa; Vanneman Matthew; Munshi Nikhil C; Tai Yu-Tzu; Prabhala Rao H; Ritz Jerome; Neuberg Donna; Anderson Kenneth C; Carrasco Daniel Ruben; Dranoff Glenn
MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(4):1285-90.
-
2007: Munshi Nikhil C
Monoclonal gammopathy of undetermined significance: genetic vs environmental etiologies.
Mayo Clinic proceedings. Mayo Clinic 2007;82(12):1457-9.
-
2007: Prabhala Rao H; Munshi Nikhil C
Immune therapies.
Hematology/oncology clinics of North America 2007;21(6):1217-30, x-xi.
-
2007: Mitsiades Constantine S; McMillin Douglas W; Klippel Steffen; Hideshima Teru; Chauhan Dharminder; Richardson Paul G; Munshi Nikhil C; Anderson Kenneth C
The role of the bone marrow microenvironment in the pathophysiology of myeloma and its significance in the development of more effective therapies.
Hematology/oncology clinics of North America 2007;21(6):1007-34, vii-viii.
-
2007: Neri P; Tassone P; Shammas M; Yasui H; Schipani E; Batchu R B; Blotta S; Prabhala R; Catley L; Hamasaki M; Hideshima T; Chauhan D; Jacob G S; Picker D; Venuta S; Anderson K C; Munshi N C
Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(12):2519-26.
-
2007: Stadtmauer Edward A; Lonial Sagar; Vesole David H; Abonour Rafat; Alsina Melissa; Badros Ashraf; Comenzo Raymond; Durie Brian; Giralt Sergio; Hussein Mohamad; Jakubowiak Andrzej; Mehta Jayesh; Niesvizky Ruben; Orlowski Robert; Siegel David; Singhal Seema; Vescio Robert; Wang Michael; Zangari Maurizio; Munshi Nikhil C
A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings.
Clinical advances in hematology & oncology : H&O 2007;5(10 Suppl 15):7-19, quiz 21-2.
-
2007: Neri Paola; Kumar Shaji; Fulciniti Maria Teresa; Vallet Sonia; Chhetri Shweta; Mukherjee Sidhartha; Tai Yutzu; Chauhan Dharminder; Tassone Pierfrancesco; Venuta Salvatore; Munshi Nikhil C; Hideshima Teru; Anderson Kenneth C; Raje Noopur
Neutralizing B-cell activating factor antibody improves survival and inhibits osteoclastogenesis in a severe combined immunodeficient human multiple myeloma model.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(19):5903-9.
-
2007: Breitkreutz Iris; Raab Marc S; Vallet Sonia; Hideshima Teru; Raje Noopur; Chauhan Dharminder; Munshi Nikhil C; Richardson Paul G; Anderson Kenneth C
Targeting MEK1/2 blocks osteoclast differentiation, function and cytokine secretion in multiple myeloma.
British journal of haematology 2007;139(1):55-63.
-
2007: Ditzel Santos Daniel; Ho Allen W; Tournilhac Olivier; Hatjiharissi Evdoxia; Leleu Xavier; Xu Lian; Tassone Pierfrancesco; Neri Paola; Hunter Zachary R; Chemaly Mariana A Z; Branagan Andrew R; Manning Robert J; Patterson Christopher J; Moreau Anne Sophie; Ciccarelli Bryan; Adamia Sophia; Kriangkum Jitra; Kutok Jeffery L; Tai Yu-Tzu; Zhang Jiangwen; Pilarski Linda M; Anderson Kenneth C; Munshi Nikhil; Treon Steven P
Establishment of BCWM.1 cell line for Waldenström's macroglobulinemia with productive in vivo engraftment in SCID-hu mice.
Experimental hematology 2007;35(9):1366-75.
-
2007: Hideshima Teru; Catley Laurence; Raje Noopur; Chauhan Dharminder; Podar Klaus; Mitsiades Constantine; Tai Yu-Tzu; Vallet Sonia; Kiziltepe Tanyel; Ocio Enrique; Ikeda Hiroshi; Okawa Yutaka; Hideshima Hiromasa; Munshi Nikhil C; Yasui Hiroshi; Richardson Paul G; Anderson Kenneth C
Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cells.
British journal of haematology 2007;138(6):783-91.
-
2007: Tai Yu-Tzu; Fulciniti Mariateresa; Hideshima Teru; Song Weihua; Leiba Merav; Li Xian-Feng; Rumizen Matthew; Burger Peter; Morrison Aileen; Podar Klaus; Chauhan Dharminder; Tassone Pierfrancesco; Richardson Paul; Munshi Nikhil C; Ghobrial Irene M; Anderson Kenneth C
Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis.
Blood 2007;110(5):1656-63.
-
2007: Lee Alfred Ian; Munshi Nikhil C
Integration of novel agents into treatment of myeloma.
Clinical lymphoma & myeloma 2007;7 Suppl 5():S215-21.
-
2007: Catley Laurence; Hideshima Teru; Chauhan Dharminder; Neri Paola; Tassone Pierfrancesco; Bronson Roderick; Song Weihua; Tai Yu-Tzu; Munshi Nikhil C; Anderson Kenneth C
Alkyl phospholipid perifosine induces myeloid hyperplasia in a murine myeloma model.
Experimental hematology 2007;35(7):1038-46.
-
2007: Mitsiades Constantine S; Mitsiades Nicholas S; Richardson Paul G; Munshi Nikhil C; Anderson Kenneth C
Multiple myeloma: a prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironment.
Journal of cellular biochemistry 2007;101(4):950-68.
-
2007: Munshi Nikhil C; Mitsiades Constantine S; Richardson Paul G; Anderson Kenneth C
Does maintenance therapy with thalidomide benefit patients with multiple myeloma?
Nature clinical practice. Oncology 2007;4(7):394-5.
-
2007: Richardson Paul G; Mitsiades Constantine; Schlossman Robert; Munshi Nikhil; Anderson Kenneth
New drugs for myeloma.
The oncologist 2007;12(6):664-89.
-
2007: Bae Jooeun; Mitsiades Constantine; Tai Yu-Tzu; Bertheau Robert; Shammas Masood; Batchu Ramesh Babu; Li Cheng; Catley Lawrence; Prabhala Rao; Anderson Kenneth C; Munshi Nikhil C
Phenotypic and functional effects of heat shock protein 90 inhibition on dendritic cell.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(12):7730-7.
-
2007: Carrasco Daniel R; Sukhdeo Kumar; Protopopova Marina; Sinha Raktim; Enos Miriam; Carrasco Daniel E; Zheng Mei; Mani Mala; Henderson Joel; Pinkus Geraldine S; Munshi Nikhil; Horner James; Ivanova Elena V; Protopopov Alexei; Anderson Kenneth C; Tonon Giovanni; DePinho Ronald A
The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis.
Cancer cell 2007;11(4):349-60.
-
2007: Chauhan D; Velankar M; Brahmandam M; Hideshima T; Podar K; Richardson P; Schlossman R; Ghobrial I; Raje N; Munshi N; Anderson K C
A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma.
Oncogene 2007;26(16):2374-80.
-
2007: Chanan-Khan Asher A; Kaufman Jonathan L; Mehta Jayesh; Richardson Paul G; Miller Kena C; Lonial Sagar; Munshi Nikhil C; Schlossman Robert; Tariman Joseph; Singhal Seema
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study.
Blood 2007;109(6):2604-6.
-
2007: Bellucci Roberto; Oertelt Sabine; Gallagher Meagan; Li Sigui; Zorn Emmanuel; Weller Edie; Porcheray Fabrice; Alyea Edwin P; Soiffer Robert J; Munshi Nikhil C; Gershwin M Eric; Ritz Jerome
Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis.
Blood 2007;109(5):2001-7.
-
2007: Koreth John; Cutler Corey S; Djulbegovic Benjamin; Behl Rajesh; Schlossman Robert L; Munshi Nikhil C; Richardson Paul G; Anderson Kenneth C; Soiffer Robert J; Alyea Edwin P
High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(2):183-96.
-
2007: Chauhan Dharminder; Neri Paola; Velankar Mugdha; Podar Klaus; Hideshima Teru; Fulciniti Mariateresa; Tassone Pierfrancesco; Raje Noopur; Mitsiades Constantine; Mitsiades Nicholas; Richardson Paul; Zawel Leigh; Tran Mary; Munshi Nikhil; Anderson Kenneth C
Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM).
Blood 2007;109(3):1220-7.
-
2007: Podar Klaus; Raab Marc S; Zhang Jing; McMillin Douglas; Breitkreutz Iris; Tai Yu-Tzu; Lin Boris K; Munshi Nikhil; Hideshima Teru; Chauhan Dharminder; Anderson Kenneth C
Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl).
Blood 2007;109(4):1669-77.
-
2007: Richardson Paul; Mitsiades Constantine; Schlossman Robert; Ghobrial Irene; Hideshima Teru; Chauhan Dharminder; Munshi Nikhil; Anderson Kenneth
The treatment of relapsed and refractory multiple myeloma.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2007;():317-23.
-
2006: Richardson Paul G; Mitsiades Constantine S; Munshi Nikhil C; Anderson Kenneth C
Can thalidomide improve outcome in patients with multiple myeloma?
Nature clinical practice. Oncology 2006;3(11):590-1.
-
2006: Richardson Paul G; Blood Emily; Mitsiades Constantine S; Jagannath Sundar; Zeldenrust Steven R; Alsina Melissa; Schlossman Robert L; Rajkumar S Vincent; Desikan K Raman; Hideshima Teru; Munshi Nikhil C; Kelly-Colson Kathleen; Doss Deborah; McKenney Mary L; Gorelik Svetlana; Warren Diane; Freeman Andrea; Rich Rebecca; Wu Anfang; Olesnyckyj Marta; Wride Kenton; Dalton William S; Zeldis Jerome; Knight Robert; Weller Edie; Anderson Kenneth C
A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma.
Blood 2006;108(10):3458-64.
-
2006: Catley Laurence; Weisberg Ellen; Kiziltepe Tanyel; Tai Yu-Tzu; Hideshima Teru; Neri Paola; Tassone Pierfrancesco; Atadja Peter; Chauhan Dharminder; Munshi Nikhil C; Anderson Kenneth C
Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells.
Blood 2006;108(10):3441-9.
-
2006: Hideshima Teru; Neri Paola; Tassone Pierfranchesco; Yasui Hiroshi; Ishitsuka Kenji; Raje Noopur; Chauhan Dharminder; Podar Klaus; Mitsiades Constantine; Dang Lenny; Munshi Nikhil; Richardson Paul; Schenkein David; Anderson Kenneth C
MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(19):5887-94.
-
2006: Barlogie Bart; Tricot Guido J; van Rhee Frits; Angtuaco Edguardo; Walker Ron; Epstein Joshua; Shaughnessy John D; Jagannath Sundar; Bolejack Vanessa; Gurley Jennifer; Hoering Antje; Vesole David; Desikan Raman; Siegel David; Mehta Jayesh; Singhal Seema; Munshi Nikhil C; Dhodapkar Madhav; Jenkins Bonnie; Attal Michel; Harousseau Jean-Luc; Crowley John
Long-term outcome results of the first tandem autotransplant trial for multiple myeloma.
British journal of haematology 2006;135(2):158-64.
-
2006: Raje N; Kumar S; Hideshima T; Ishitsuka K; Yasui H; Chhetri S; Vallet S; Vonescu E; Shiraishi N; Kiziltepe T; Elford H L; Munshi N C; Anderson K C
Didox, a ribonucleotide reductase inhibitor, induces apoptosis and inhibits DNA repair in multiple myeloma cells.
British journal of haematology 2006;135(1):52-61.
-
2006: Shammas Masood A; Neri Paola; Koley Hemanta; Batchu Ramesh B; Bertheau Robert C; Munshi Vidit; Prabhala Rao; Fulciniti Mariateresa; Tai Yu Tzu; Treon Steven P; Goyal Raj K; Anderson Kenneth C; Munshi Nikhil C
Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications.
Blood 2006;108(8):2804-10.
-
2006: Tournilhac O; Santos D D; Xu L; Kutok J; Tai Y-T; Le Gouill S; Catley L; Hunter Z; Branagan A R; Boyce J A; Munshi N; Anderson K C; Treon S P
Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signaling.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(8):1275-82.
-
2006: Shringarpure Reshma; Catley Laurence; Bhole Deepak; Burger Renate; Podar Klaus; Tai Yu-Tzu; Kessler Benedikt; Galardy Paul; Ploegh Hidde; Tassone Pierfrancesco; Hideshima Teru; Mitsiades Constantine; Munshi Nikhil C; Chauhan Dharminder; Anderson Kenneth C
Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib.
British journal of haematology 2006;134(2):145-56.
-
2006: Tai Yu-Tzu; Li Xian-Feng; Breitkreutz Iris; Song Weihua; Neri Paola; Catley Laurence; Podar Klaus; Hideshima Teru; Chauhan Dharminder; Raje Noopur; Schlossman Robert; Richardson Paul; Munshi Nikhil C; Anderson Kenneth C
Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
Cancer research 2006;66(13):6675-82.
-
2006: Neri Paola; Yasui Hiroshi; Hideshima Teru; Tassone Pierfrancesco; Raje Noopur; Catley Laurence P; Ishitsuka Kenji; Blotta Simona; Kiziltepe Tanyel; Ocio Enrique M; Fulciniti Mariateresa; Kanekal Sarath; Elliott Gary T; Munshi Nikhil C; Anderson Kenneth C
In vivo and in vitro cytotoxicity of R-etodolac with dexamethasone in glucocorticoid-resistant multiple myeloma cells.
British journal of haematology 2006;134(1):37-44.
-
2006: Mitsiades Constantine S; Mitsiades Nicholas S; Munshi Nikhil C; Richardson Paul G; Anderson Kenneth C
The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: interplay of growth factors, their receptors and stromal interactions.
European journal of cancer (Oxford, England : 1990) 2006;42(11):1564-73.
-
2006: Hideshima Teru; Catley Laurence; Yasui Hiroshi; Ishitsuka Kenji; Raje Noopur; Mitsiades Constantine; Podar Klaus; Munshi Nikhil C; Chauhan Dharminder; Richardson Paul G; Anderson Kenneth C
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells.
Blood 2006;107(10):4053-62.
-
2006: Kumar Shaji; Raje Noopur; Hideshima Teru; Ishitsuka Kenji; Podar Klaus; Le Gouille Steven; Chauhan Dharminder; Richardson Paul; Munshi Nikhil C; Anderson Kenneth
FQPD, a novel immunomodulatory drug, has significant in vitro activity in multiple myeloma.
British journal of haematology 2006;132(6):698-704.
-
2006: Mitsiades Constantine S; Mitsiades Nicholas S; McMullan Ciaran J; Poulaki Vassiliki; Kung Andrew L; Davies Faith E; Morgan Gareth; Akiyama Masaharu; Shringarpure Reshma; Munshi Nikhil C; Richardson Paul G; Hideshima Teru; Chauhan Dharminder; Gu Xuesong; Bailey Charles; Joseph Marie; Libermann Towia A; Rosen Neal S; Anderson Kenneth C
Antimyeloma activity of heat shock protein-90 inhibition.
Blood 2006;107(3):1092-100.
-
2006: Prabhala Rao H; Neri Paola; Bae Jooeun E; Tassone Pierfrancesco; Shammas Masood A; Allam Charles K; Daley John F; Chauhan Dharminder; Blanchard Elizabeth; Thatte Hemant S; Anderson Kenneth C; Munshi Nikhil C
Dysfunctional T regulatory cells in multiple myeloma.
Blood 2006;107(1):301-4.
-
2005: Tai Yu-Tzu; Li Xian-Feng; Catley Laurence; Coffey Rory; Breitkreutz Iris; Bae Jooeun; Song Weihua; Podar Klaus; Hideshima Teru; Chauhan Dharminder; Schlossman Robert; Richardson Paul; Treon Steven P; Grewal Iqbal S; Munshi Nikhil C; Anderson Kenneth C
Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: clinical implications.
Cancer research 2005;65(24):11712-20.
-
2005: Richardson Paul G; Schlossman Robert; Mitsiades Constantine; Hideshima Teru; Munshi Nikhil; Anderson Kenneth
Emerging trends in the clinical use of bortezomib in multiple myeloma.
Clinical lymphoma & myeloma 2005;6(2):84-8.
-
2005: Neelapu S S; Munshi N C; Jagannath S; Watson T M; Pennington R; Reynolds C; Barlogie B; Kwak L W
Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma.
Bone marrow transplantation 2005;36(4):315-23.
-
2005: Tassone Pierfrancesco; Neri Paola; Kutok Jeffery L; Tournilhac Olivier; Santos Daniel Ditzel; Hatjiharissi Evdoxia; Munshi Vidit; Venuta Salvatore; Anderson Kenneth C; Treon Steven P; Munshi Nikhil C
A SCID-hu in vivo model of human Waldenström macroglobulinemia.
Blood 2005;106(4):1341-5.
-
2005: Raje Noopur; Kumar Shaji; Hideshima Teru; Roccaro Aldo; Ishitsuka Kenji; Yasui Hiroshi; Shiraishi Norihiko; Chauhan Dharminder; Munshi Nikhil C; Green Simon R; Anderson Kenneth C
Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma.
Blood 2005;106(3):1042-7.
-
2005: Tai Yu-Tzu; Li Xianfeng; Tong Xia; Santos Daniel; Otsuki Takemi; Catley Laurence; Tournilhac Olivier; Podar Klaus; Hideshima Teru; Schlossman Robert; Richardson Paul; Munshi Nikhil C; Luqman Mohammad; Anderson Kenneth C
Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma.
Cancer research 2005;65(13):5898-906.
-
2005: Kumar S; Raje N; Hideshima T; Ishitsuka K; Roccaro A; Shiraishi N; Hamasaki M; Yasui H; Munshi N C; Richardson P; Figg W D; Anderson K C
Antimyeloma activity of two novel N-substituted and tetraflourinated thalidomide analogs.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(7):1253-61.
-
2005: Tassone Pierfrancesco; Neri Paola; Carrasco Daniel R; Burger Renate; Goldmacher Victor S; Fram Robert; Munshi Vidit; Shammas Masood A; Catley Laurence; Jacob Gary S; Venuta Salvatore; Anderson Kenneth C; Munshi Nikhil C
A clinically relevant SCID-hu in vivo model of human multiple myeloma.
Blood 2005;106(2):713-6.
-
2005: Yasui Hiroshi; Hideshima Teru; Hamasaki Makoto; Roccaro Aldo M; Shiraishi Norihiko; Kumar Shaji; Tassone Pierfrancesco; Ishitsuka Kenji; Raje Noopur; Tai Yu-Tzu; Podar Klaus; Chauhan Dharminder; Leoni Lorenzo M; Kanekal Sarath; Elliott Gary; Munshi Nikhil C; Anderson Kenneth C
SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma.
Blood 2005;106(2):706-12.
-
2005: Tassone Pierfrancesco; Neri Paola; Burger Renate; Savino Rocco; Shammas Masood; Catley Laurence; Podar Klaus; Chauhan Dharminder; Masciari Serena; Gozzini Antonella; Tagliaferri Pierosandro; Venuta Salvatore; Munshi Nikhil C; Anderson Kenneth C
Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(11):4251-8.
-
2005: Hamasaki Makoto; Hideshima Teru; Tassone Pierfrancesco; Neri Paola; Ishitsuka Kenji; Yasui Hiroshi; Shiraishi Norihiko; Raje Noopur; Kumar Shaji; Picker Donald H; Jacob Gary S; Richardson Paul G; Munshi Nikhil C; Anderson Kenneth C
Azaspirane (N-N-diethyl-8,8-dipropyl-2-azaspiro [4.5] decane-2-propanamine) inhibits human multiple myeloma cell growth in the bone marrow milieu in vitro and in vivo.
Blood 2005;105(11):4470-6.
-
2005: Bellucci Roberto; Alyea Edwin P; Chiaretti Sabina; Wu Catherine J; Zorn Emmanuel; Weller Edie; Wu Bingyan; Canning Christine; Schlossman Robert; Munshi Nikhil C; Anderson Kenneth C; Ritz Jerome
Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor.
Blood 2005;105(10):3945-50.
-
2005: Hideshima Teru; Chauhan Dharminder; Ishitsuka Kenji; Yasui Hiroshi; Raje Noopur; Kumar Shaji; Podar Klaus; Mitsiades Constantine; Hideshima Hiromasa; Bonham Lynn; Munshi Nikhil C; Richardson Paul G; Singer Jack W; Anderson Kenneth C
Molecular characterization of PS-341 (bortezomib) resistance: implications for overcoming resistance using lysophosphatidic acid acyltransferase (LPAAT)-beta inhibitors.
Oncogene 2005;24(19):3121-9.
-
2005: Shammas Masood A; Koley Hemanta; Batchu Ramesh B; Bertheau Robert C; Protopopov Alexei; Munshi Nikhil C; Goyal Raj K
Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential.
Molecular cancer 2005;4():24.
-
2004: Catley Laurence; Tai Yu-Tzu; Shringarpure Reshma; Burger Renate; Son Moni Thi; Podar Klaus; Tassone Pierfrancesco; Chauhan Dharminder; Hideshima Teru; Denis Louis; Richardson Paul; Munshi Nikhil C; Anderson Kenneth C
Proteasomal degradation of topoisomerase I is preceded by c-Jun NH2-terminal kinase activation, Fas up-regulation, and poly(ADP-ribose) polymerase cleavage in SN38-mediated cytotoxicity against multiple myeloma.
Cancer research 2004;64(23):8746-53.
-
2004: Raje Noopur; Kumar Shaji; Hideshima Teru; Ishitsuka Kenji; Chauhan Dharminder; Mitsiades Constantine; Podar Klaus; Le Gouill Steven; Richardson Paul; Munshi Nikhil C; Stirling David I; Antin Joseph H; Anderson Kenneth C
Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma.
Blood 2004;104(13):4188-93.
-
2004: Tassone Pierfrancesco; Goldmacher Victor S; Neri Paola; Gozzini Antonella; Shammas Masood A; Whiteman Kathleen R; Hylander-Gans Linda L; Carrasco Daniel R; Hideshima Teru; Shringarpure Reshma; Shi Jialan; Allam Charles K; Wijdenes John; Venuta Salvatore; Munshi Nikhil C; Anderson Kenneth C
Cytotoxic activity of the maytansinoid immunoconjugate B-B4-DM1 against CD138+ multiple myeloma cells.
Blood 2004;104(12):3688-96.
-
2004: Mitsiades Constantine S; Mitsiades Nicholas; Munshi Nikhil C; Anderson Kenneth C
Focus on multiple myeloma.
Cancer cell 2004;6(5):439-44.
-
2004: Hideshima Teru; Podar Klaus; Chauhan Dharminder; Ishitsuka Kenji; Mitsiades Constantine; Tai Yu-Tzu; Hamasaki Makoto; Raje Noopur; Hideshima Hiromasa; Schreiner George; Nguyen Aaron N; Navas Tony; Munshi Nikhil C; Richardson Paul G; Higgins Linda S; Anderson Kenneth C
p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells.
Oncogene 2004;23(54):8766-76.
-
2004: Chauhan Dharminder; Li Guilan; Podar Klaus; Hideshima Teru; Mitsiades Constantine; Schlossman Robert; Munshi Nikhil; Richardson Paul; Cotter Finbarr E; Anderson Kenneth C
Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells.
Blood 2004;104(8):2458-66.
-
2004: Dring Ann M; Davies Faith E; Fenton James A L; Roddam Philippa L; Scott Kathryn; Gonzalez David; Rollinson Sara; Rawstron Andrew C; Rees-Unwin Karen S; Li Cheng; Munshi Nikhil C; Anderson Kenneth C; Morgan Gareth J
A global expression-based analysis of the consequences of the t(4;14) translocation in myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(17):5692-701.
-
2004: Tassone Pierfrancesco; Gozzini Antonella; Goldmacher Victor; Shammas Masood A; Whiteman Kathleen R; Carrasco Daniel R; Li Cheng; Allam Charles K; Venuta Salvatore; Anderson Kenneth C; Munshi Nikhil C
In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cells.
Cancer research 2004;64(13):4629-36.
-
2004: Klein Walter M; Rencic Adrienne; Munshi Nikhil C; Nousari Carlos H
Multicentric plasma cell variant of Castleman's disease with cutaneous involvement.
Journal of cutaneous pathology 2004;31(6):448-52.
-
2004: Shammas Masood A; Koley Hemanta; Beer David G; Li Cheng; Goyal Raj K; Munshi Nikhil C
Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitor.
Gastroenterology 2004;126(5):1337-46.
-
2004: Munshi Nikhil C
Recent advances in the management of multiple myeloma.
Seminars in hematology 2004;41(2 Suppl 4):21-6.
-
2004: Chauhan Dharminder; Li Guilan; Hideshima Teru; Podar Klaus; Shringarpure Reshma; Mitsiades Constantine; Munshi Nikhil; Yew P Renee; Anderson Kenneth C
Blockade of ubiquitin-conjugating enzyme CDC34 enhances anti-myeloma activity of Bortezomib/Proteasome inhibitor PS-341.
Oncogene 2004;23(20):3597-602.
-
2004: Tai Yu-Tzu; Catley Laurence P; Mitsiades Constantine S; Burger Renate; Podar Klaus; Shringpaure Reshma; Hideshima Teru; Chauhan Dharminder; Hamasaki Makoto; Ishitsuka Kenji; Richardson Paul; Treon Steven P; Munshi Nikhil C; Anderson Kenneth C
Mechanisms by which SGN-40, a humanized anti-CD40 antibody, induces cytotoxicity in human multiple myeloma cells: clinical implications.
Cancer research 2004;64(8):2846-52.
-
2004: Chauhan Dharminder; Li Guilan; Podar Klaus; Hideshima Teru; Shringarpure Reshma; Catley Laurence; Mitsiades Constantine; Munshi Nikhil; Tai Yu Tzu; Suh Nanjoo; Gribble Gordon W; Honda Tadashi; Schlossman Robert; Richardson Paul; Sporn Michael B; Anderson Kenneth C
The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistance.
Blood 2004;103(8):3158-66.
-
2004: Chauhan D; Li G; Auclair D; Hideshima T; Podar K; Mitsiades N; Mitsiades C; Chen L B; Munshi N; Saxena S; Anderson K C
2-Methoxyestardiol and bortezomib/proteasome-inhibitor overcome dexamethasone-resistance in multiple myeloma cells by modulating Heat Shock Protein-27.
Apoptosis : an international journal on programmed cell death 2004;9(2):149-55.
-
2004: LeBlanc Richard; Hideshima Teru; Catley Laurence P; Shringarpure Reshma; Burger Renate; Mitsiades Nicholas; Mitsiades Constantine; Cheema Puneet; Chauhan Dharminder; Richardson Paul G; Anderson Kenneth C; Munshi Nikhil C
Immunomodulatory drug costimulates T cells via the B7-CD28 pathway.
Blood 2004;103(5):1787-90.
-
2004: Munshi Nikhil C; Hideshima Teru; Carrasco Daniel; Shammas Masood; Auclair Daniel; Davies Faith; Mitsiades Nicholas; Mitsiades Constantine; Kim Ryung Suk; Li Cheng; Rajkumar S Vincent; Fonseca Rafael; Bergsagel Lief; Chauhan Dharminder; Anderson Kenneth C
Identification of genes modulated in multiple myeloma using genetically identical twin samples.
Blood 2004;103(5):1799-806.
-
2004: Barri Yousri M; Munshi Nikhil C; Sukumalchantra Suteetat; Abulezz Sameh R; Bonsib Stephen M; Wallach Jeffrey; Walker Patrick D
Podocyte injury associated glomerulopathies induced by pamidronate.
Kidney international 2004;65(2):634-41.
-
2004: Shammas Masood A; Shmookler Reis Robert J; Li Cheng; Koley Hemanta; Hurley Laurence H; Anderson Kenneth C; Munshi Nikhil C
Telomerase inhibition and cell growth arrest after telomestatin treatment in multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(2):770-6.
-
2004: Mitsiades Constantine S; Mitsiades Nicholas S; McMullan Ciaran J; Poulaki Vassiliki; Shringarpure Reshma; Hideshima Teru; Akiyama Masaharu; Chauhan Dharminder; Munshi Nikhil; Gu Xuesong; Bailey Charles; Joseph Marie; Libermann Towia A; Richon Victoria M; Marks Paul A; Anderson Kenneth C
Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(2):540-5.
-
2004: Bellucci Roberto; Wu Catherine J; Chiaretti Sabina; Weller Edie; Davies Faith E; Alyea Edwin P; Dranoff Glenn; Anderson Kenneth C; Munshi Nikhil C; Ritz Jerome
Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens.
Blood 2004;103(2):656-63.
-
2003: Hideshima Teru; Chauhan Dharminder; Hayashi Toshiaki; Podar Klaus; Akiyama Masaharu; Mitsiades Constantine; MItsiades Nicholas; Gong Baoqing; Bonham Lynn; de Vries Peter; Munshi Nikhil; Richardson Paul G; Singer Jack W; Anderson Kenneth C
Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma.
Cancer research 2003;63(23):8428-36.
-
2003: Davies Faith E; Dring Ann M; Li Cheng; Rawstron Andrew C; Shammas Masood A; O'Connor Sheila M; Fenton James A L; Hideshima Teru; Chauhan Dharminder; Tai Isabella T; Robinson Elizabeth; Auclair Daniel; Rees Karen; Gonzalez David; Ashcroft A John; Dasgupta Ranjit; Mitsiades Constantine; Mitsiades Nicholas; Chen Lan B; Wong Wing H; Munshi Nikhil C; Morgan Gareth J; Anderson Kenneth C
Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis.
Blood 2003;102(13):4504-11.
-
2003: Hideshima Teru; Chauhan Dharminder; Hayashi Toshiaki; Akiyama Masaharu; Mitsiades Nicholas; Mitsiades Constantine; Podar Klaus; Munshi Nikhil C; Richardson Paul G; Anderson Kenneth C
Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myeloma.
Oncogene 2003;22(52):8386-93.
-
2003: Chauhan Dharminder; Li Guilan; Hideshima Teru; Podar Klaus; Mitsiades Constantine; Mitsiades Nicholas; Catley Laurence; Tai Yu Tzu; Hayashi Toshiaki; Shringarpure Reshma; Burger Renate; Munshi Nikhil; Ohtake Yasuyuki; Saxena Satya; Anderson Kenneth C
Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistance.
Blood 2003;102(9):3379-86.
-
2003: Mitsiades Constantine S; Mitsiades Nicholas S; Bronson Ron T; Chauhan Dharminder; Munshi Nikhil; Treon Steven P; Maxwell Christopher A; Pilarski Linda; Hideshima Teru; Hoffman Robert M; Anderson Kenneth C
Fluorescence imaging of multiple myeloma cells in a clinically relevant SCID/NOD in vivo model: biologic and clinical implications.
Cancer research 2003;63(20):6689-96.
-
2003: Akiyama Masaharu; Hideshima Teru; Shammas Masood A; Hayashi Toshiaki; Hamasaki Makoto; Tai Yu-Tzu; Richardson Paul; Gryaznov Sergei; Munshi Nikhil C; Anderson Kenneth C
Effects of oligonucleotide N3'-->P5' thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cells.
Cancer research 2003;63(19):6187-94.
-
2003: Catley Laurence; Weisberg Ellen; Tai Yu-Tzu; Atadja Peter; Remiszewski Stacy; Hideshima Teru; Mitsiades Nicholas; Shringarpure Reshma; LeBlanc Richard; Chauhan Dharminder; Munshi Nikhil C; Schlossman Robert; Richardson Paul; Griffin James; Anderson Kenneth C
NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma.
Blood 2003;102(7):2615-22.
-
2003: Shammas Masood A; Shmookler Reis Robert J; Akiyama Masaharu; Koley Hemanta; Chauhan Dharminder; Hideshima Teru; Goyal Raj K; Hurley Laurence H; Anderson Kenneth C; Munshi Nikhil C
Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma.
Molecular cancer therapeutics 2003;2(9):825-33.
-
2003: Tai Yu-Tzu; Podar Klaus; Catley Laurence; Tseng Yu-Hua; Akiyama Masaharu; Shringarpure Reshma; Burger Renate; Hideshima Teru; Chauhan Dharminder; Mitsiades Nicholas; Richardson Paul; Munshi Nikhil C; Kahn C Ronald; Mitsiades Constantine; Anderson Kenneth C
Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3'-kinase/AKT signaling.
Cancer research 2003;63(18):5850-8.
-
2003: Chauhan Dharminder; Li Guilan; Sattler Martin; Podar Klaus; Mitsiades Constantine; Mitsiades Nicholas; Munshi Nikhil; Hideshima Teru; Anderson Kenneth C
Superoxide-dependent and -independent mitochondrial signaling during apoptosis in multiple myeloma cells.
Oncogene 2003;22(40):6296-300.
-
2003: Maecker Britta; Anderson Karen S; von Bergwelt-Baildon Michael S; Weller Edie; Vonderheide Robert H; Richardson Paul G; Schlossman Robert L; Menezes Isaura A; Xia Zhinan; Munshi Nikhil C; Anderson Kenneth C; Nadler Lee M; Schultze Joachim L
Viral antigen-specific CD8+ T-cell responses are impaired in multiple myeloma.
British journal of haematology 2003;121(6):842-8.
-
2003: Chauhan Dharminder; Li Guilan; Hideshima Teru; Podar Klaus; Mitsiades Constantine; Mitsiades Nicholas; Munshi Nikhil; Kharbanda Surender; Anderson Kenneth C
JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells.
The Journal of biological chemistry 2003;278(20):17593-6.
-
2003: Mitsiades Nicholas; Mitsiades Constantine S; Richardson Paul G; McMullan Ciaran; Poulaki Vassiliki; Fanourakis Galinos; Schlossman Robert; Chauhan Dharminder; Munshi Nikhil C; Hideshima Teru; Richon Victoria M; Marks Paul A; Anderson Kenneth C
Molecular sequelae of histone deacetylase inhibition in human malignant B cells.
Blood 2003;101(10):4055-62.
-
2003: Chauhan Dharminder; Li Guilan; Auclair Daniel; Hideshima Teru; Richardson Paul; Podar Klaus; Mitsiades Nicholas; Mitsiades Constantine; Li Cheng; Kim Ryung Suk; Munshi Nikhil; Chen Lan Bo; Wong Wing; Anderson Kenneth C
Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays.
Blood 2003;101(9):3606-14.
-
2003: Munshi N C; Barlogie B
Role for high-dose therapy with autologous hematopoietic stem cell support in Waldenstrom's macroglobulinemia.
Seminars in oncology 2003;30(2):282-5.
-
2003: Gertz Morie A; Anagnostopoulos Athanasios; Anderson Kenneth; Branagan Andrew R; Coleman Morton; Frankel Stanley R; Giralt Sergio; Levine Todd; Munshi Nikhil; Pestronk Alan; Rajkumar Vincent; Treon Steven P
Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Seminars in oncology 2003;30(2):121-6.
-
2003: Tai Yu-Tzu; Podar Klaus; Mitsiades Nicholas; Lin Boris; Mitsiades Constantine; Gupta Deepak; Akiyama Masaharu; Catley Laurence; Hideshima Teru; Munshi Nikhil C; Treon Steven P; Anderson Kenneth C
CD40 induces human multiple myeloma cell migration via phosphatidylinositol 3-kinase/AKT/NF-kappa B signaling.
Blood 2003;101(7):2762-9.
-
2003: Mitsiades Nicholas; Mitsiades Constantine S; Richardson Paul G; Poulaki Vassiliki; Tai Yu-Tzu; Chauhan Dharminder; Fanourakis Galinos; Gu Xuesong; Bailey Charles; Joseph Marie; Libermann Towia A; Schlossman Robert; Munshi Nikhil C; Hideshima Teru; Anderson Kenneth C
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications.
Blood 2003;101(6):2377-80.
-
2003: Podar Klaus; Tai Yu-Tzu; Cole Craig E; Hideshima Teru; Sattler Martin; Hamblin Angela; Mitsiades Nicholas; Schlossman Robert L; Davies Faith E; Morgan Gareth J; Munshi Nikhil C; Chauhan Dharminder; Anderson Kenneth C
Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells.
The Journal of biological chemistry 2003;278(8):5794-801.
-
2003: Hideshima Teru; Mitsiades Constantine; Akiyama Masaharu; Hayashi Toshiaki; Chauhan Dharminder; Richardson Paul; Schlossman Robert; Podar Klaus; Munshi Nikhil C; Mitsiades Nicholas; Anderson Kenneth C
Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341.
Blood 2003;101(4):1530-4.
-
2003: Akiyama Masaharu; Hideshima Teru; Hayashi Toshiaki; Tai Yu-Tzu; Mitsiades Constantine S; Mitsiades Nicholas; Chauhan Dharminder; Richardson Paul; Munshi Nikhil C; Anderson Kenneth C
Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein.
Cancer research 2003;63(1):18-21.
-
2003: Iyer Rajaraman; Ding LieMing; Batchu Ramesh B; Naugler Scott; Shammas Masood A; Munshi Nikhil C
Antisense p53 transduction leads to overexpression of bcl-2 and dexamethasone resistance in multiple myeloma.
Leukemia research 2003;27(1):73-8.
-
2002: Mitsiades Nicholas; Mitsiades Constantine S; Poulaki Vassiliki; Chauhan Dharminder; Fanourakis Galinos; Gu Xuesong; Bailey Charles; Joseph Marie; Libermann Towia A; Treon Steven P; Munshi Nikhil C; Richardson Paul G; Hideshima Teru; Anderson Kenneth C
Molecular sequelae of proteasome inhibition in human multiple myeloma cells.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(22):14374-9.
-
2002: Akiyama Masaharu; Hideshima Teru; Munshi Nikhil C; Anderson Kenneth C
Telomerase inhibitors as anticancer therapy.
Current medicinal chemistry. Anti-cancer agents 2002;2(5):567-75.
-
2002: Lin Boris; Podar Klaus; Gupta Deepak; Tai Yu-Tzu; Li Sigui; Weller Edie; Hideshima Teru; Lentzsch Suzanne; Davies Faith; Li Cheng; Weisberg Ellen; Schlossman Robert L; Richardson Paul G; Griffin James D; Wood Jeanette; Munshi Nikhil C; Anderson Kenneth C
The vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584 inhibits growth and migration of multiple myeloma cells in the bone marrow microenvironment.
Cancer research 2002;62(17):5019-26.
-
2002: LeBlanc Richard; Catley Laurence P; Hideshima Teru; Lentzsch Suzanne; Mitsiades Constantine S; Mitsiades Nicholas; Neuberg Donna; Goloubeva Olga; Pien Christine S; Adams Julian; Gupta Deepak; Richardson Paul G; Munshi Nikhil C; Anderson Kenneth C
Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model.
Cancer research 2002;62(17):4996-5000.
-
2002: Munshi N C; Tricot G; Desikan R; Badros A; Zangari M; Toor A; Morris C; Anaissie E; Barlogie B
Clinical activity of arsenic trioxide for the treatment of multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(9):1835-7.
-
2002: Chauhan Dharminder; Catley Laurence; Hideshima Teru; Li Guilan; Leblanc Richard; Gupta Deepak; Sattler Martin; Richardson Paul; Schlossman Robert L; Podar Klaus; Weller Edie; Munshi Nikhil; Anderson Kenneth C
2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells.
Blood 2002;100(6):2187-94.
-
2002: Hayashi Toshiaki; Hideshima Teru; Akiyama Masaharu; Richardson Paul; Schlossman Robert L; Chauhan Dharminder; Munshi Nikhil C; Waxman Samuel; Anderson Kenneth C
Arsenic trioxide inhibits growth of human multiple myeloma cells in the bone marrow microenvironment.
Molecular cancer therapeutics 2002;1(10):851-60.
-
2002: Munshi Nikhil C; Hideshima Teru; Chauhan Dharminder; Richardson Paul; Anderson Kenneth C
Novel biologically based therapies for multiple myeloma.
International journal of hematology 2002;76 Suppl 1():340-1.
-
2002: Mitsiades Constantine S; Mitsiades Nicholas; Poulaki Vassiliki; Schlossman Robert; Akiyama Masaharu; Chauhan Dharminder; Hideshima Teru; Treon Steven P; Munshi Nikhil C; Richardson Paul G; Anderson Kenneth C
Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications.
Oncogene 2002;21(37):5673-83.
-
2002: Gupta Deepak; Podar Klaus; Tai Yu Tzu; Lin Boris; Hideshima Teru; Akiyama Masaharu; LeBlanc Richard; Catley Laurence; Mitsiades Nicholas; Mitsiades Constantine; Chauhan Dharminder; Munshi Nikhil C; Anderson Kenneth C
beta-lapachone, a novel plant product, overcomes drug resistance in human multiple myeloma cells.
Experimental hematology 2002;30(7):711-20.
-
2002: Akiyama Masaharu; Hideshima Teru; Hayashi Toshiaki; Tai Yu-Tzu; Mitsiades Constantine S; Mitsiades Nicholas; Chauhan Dharminder; Richardson Paul; Munshi Nikhil C; Anderson Kenneth C
Cytokines modulate telomerase activity in a human multiple myeloma cell line.
Cancer research 2002;62(13):3876-82.
-
2002: Mitsiades Nicholas; Mitsiades Constantine S; Poulaki Vassiliki; Chauhan Dharminder; Richardson Paul G; Hideshima Teru; Munshi Nikhil C; Treon Steven P; Anderson Kenneth C
Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications.
Blood 2002;99(12):4525-30.
-
2002: Mitsiades Nicholas; Mitsiades Constantine S; Poulaki Vassiliki; Chauhan Dharminder; Richardson Paul G; Hideshima Teru; Munshi Nikhil; Treon Steven P; Anderson Kenneth C
Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications.
Blood 2002;99(11):4079-86.
-
2002: Hideshima Teru; Chauhan Dharminder; Hayashi Toshiaki; Podar Klaus; Akiyama Masaharu; Gupta Deepak; Richardson Paul; Munshi Nikhil; Anderson Kenneth C
The biological sequelae of stromal cell-derived factor-1alpha in multiple myeloma.
Molecular cancer therapeutics 2002;1(7):539-44.
-
2002: Batchu Ramesh B; Shammas Masood A; Wang Jing Yi; Freeman John; Rosen Nancy; Munshi Nikhil C
Adeno-associated virus protects the retinoblastoma family of proteins from adenoviral-induced functional inactivation.
Cancer research 2002;62(10):2982-5.
-
2002: Hideshima Teru; Chauhan Dharminder; Richardson Paul; Mitsiades Constantine; Mitsiades Nicholas; Hayashi Toshiaki; Munshi Nikhil; Dang Lenny; Castro Alfredo; Palombella Vito; Adams Julian; Anderson Kenneth C
NF-kappa B as a therapeutic target in multiple myeloma.
The Journal of biological chemistry 2002;277(19):16639-47.
-
2002: Chauhan Dharminder; Auclair Daniel; Robinson Elisabeth K; Hideshima Teru; Li Guilan; Podar Klaus; Gupta Deepak; Richardson Paul; Schlossman Robert L; Krett Nancy; Chen Lan Bo; Munshi Nikhil C; Anderson Kenneth C
Identification of genes regulated by dexamethasone in multiple myeloma cells using oligonucleotide arrays.
Oncogene 2002;21(9):1346-58.
-
2002: Batchu Ramesh B; Shammas Masood A; Wang Jing Yi; Shmookler Reis Robert J; Munshi Nikhil C
Interaction of adeno-associated virus Rep78 with SV40 T antigen: implications in Rep protein expression leading to the inhibition of SV40-mediated cell proliferation.
Intervirology 2002;45(2):115-8.
-
2001: Munshi N C; Wilson C
Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis.
Seminars in oncology 2001;28(6):565-9.
-
2001: Munshi N; Agalioti T; Lomvardas S; Merika M; Chen G; Thanos D
Coordination of a transcriptional switch by HMGI(Y) acetylation.
Science (New York, N.Y.) 2001;293(5532):1133-6.
-
2001: Fedele M; Pierantoni G M; Berlingieri M T; Battista S; Baldassarre G; Munshi N; Dentice M; Thanos D; Santoro M; Viglietto G; Fusco A
Overexpression of proteins HMGA1 induces cell cycle deregulation and apoptosis in normal rat thyroid cells.
Cancer research 2001;61(11):4583-90.
-
2001: Batchu R B; Shammas M A; Wang J Y; Munshi N C
Dual level inhibition of E2F-1 activity by adeno-associated virus Rep78.
The Journal of biological chemistry 2001;276(26):24315-22.
-
2001: Butch A W; Badros A; Desikan K R; Munshi N C
Expression of a free gamma heavy chain in serum following autologous stem cell transplantation for IgG kappa multiple myeloma.
Bone marrow transplantation 2001;27(6):663-6.
-
2001: Desikan K R; Tricot G; Munshi N C; Anaissie E; Spoon D; Fassas A; Toor A; Zangari M; Badros A; Morris C; Vesole D H; Siegel D; Jagannath S; Barlogie B
Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone.
British journal of haematology 2001;112(1):242-7.
-
2001: Sawyer J R; Lukacs J L; Thomas E L; Swanson C M; Goosen L S; Sammartino G; Gilliland J C; Munshi N C; Tricot G; Shaughnessy J D; Barlogie B
Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma.
British journal of haematology 2001;112(1):167-74.
-
2001: Butch A W; Kelly K A; Munshi N C
Dendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein.
Experimental hematology 2001;29(1):85-92.
-
2001: Batchu R B; Shammas M A; Wang J Y; Shmookler Reis R J; Munshi N C
Expression of AAV Rep proteins in SV40-transformed and untransformed cells: reciprocal interaction with host DNA synthesis.
Intervirology 2001;44(5):298-305.
-
2001: Munshi N C
Arsenic trioxide: an emerging therapy for multiple myeloma.
The oncologist 2001;6 Suppl 2():17-21.
-
2000: Chau K Y; Munshi N; Keane-Myers A; Cheung-Chau K W; Tai A K; Manfioletti G; Dorey C K; Thanos D; Zack D J; Ono S J
The architectural transcription factor high mobility group I(Y) participates in photoreceptor-specific gene expression.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2000;20(19):7317-24.
-
2000: O'Neill D W; Schoetz S S; Lopez R A; Castle M; Rabinowitz L; Shor E; Krawchuk D; Goll M G; Renz M; Seelig H P; Han S; Seong R H; Park S D; Agalioti T; Munshi N; Thanos D; Erdjument-Bromage H; Tempst P; Bank A
An ikaros-containing chromatin-remodeling complex in adult-type erythroid cells.
Molecular and cellular biology 2000;20(20):7572-82.
-
2000: Desikan R; Barlogie B; Sawyer J; Ayers D; Tricot G; Badros A; Zangari M; Munshi N C; Anaissie E; Spoon D; Siegel D; Jagannath S; Vesole D; Epstein J; Shaughnessy J; Fassas A; Lim S; Roberson P; Crowley J
Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities.
Blood 2000;95(12):4008-10.
-
1999: Munshi N C; Barlogie B; Desikan K R; Wilson C
Novel approaches in myeloma therapy.
Seminars in oncology 1999;26(5 Suppl 13):28-34.
-
1999: Batchu R B; Shammas M A; Wang J Y; Munshi N C
Interaction of adeno-associated virus Rep78 with p53: implications in growth inhibition.
Cancer research 1999;59(15):3592-5.
-
1999: Desikan K R; Dhodapkar M V; Munshi N C; Barlogie B
Recent advances in the treatment of multiple myeloma.
Current opinion in hematology 1999;6(4):216-21.
-
1999: Desikan R; Dhodapkar M; Siegel D; Fassas A; Singh J; Singhal S; Mehta J; Vesole D; Tricot G; Jagannath S; Anaissie E; Barlogie B; Munshi N C
High-dose therapy with autologous haemopoietic stem cell support for Waldenström's macroglobulinaemia.
British journal of haematology 1999;105(4):993-6.
-
1999: Fassas A B; Desikan K R; Siegel D; Golper T A; Munshi N C; Barlogie B; Tricot G
Tumour lysis syndrome complicating high-dose treatment in patients with multiple myeloma.
British journal of haematology 1999;105(4):938-41.
-
1999: Yie J; Merika M; Munshi N; Chen G; Thanos D
The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome.
The EMBO journal 1999;18(11):3074-89.
-
1999: Fassas A; Jagannath S; Desikan K R; Shah H R; Shaver R; Waldron J; Munshi N C; Barlogie B; Tricot G
Lymphomatoid granulomatosis following autologous stem cell transplantation.
Bone marrow transplantation 1999;23(1):79-81.
-
1999: Munshi N; Yie Y; Merika M; Senger K; Lomvardas S; Agalioti T; Thanos D
The IFN-beta enhancer: a paradigm for understanding activation and repression of inducible gene expression.
Cold Spring Harbor symposia on quantitative biology 1999;64():149-59.
-
1998: Dhodapkar M V; Singh J; Mehta J; Fassas A; Desikan K R; Perlman M; Munshi N C; Barlogie B
Anti-myeloma activity of pamidronate in vivo.
British journal of haematology 1998;103(2):530-2.
-
1998: Munshi N; Merika M; Yie J; Senger K; Chen G; Thanos D
Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome.
Molecular cell 1998;2(4):457-67.
-
1997: Ding L; Lu S; Munshi N C
In vitro packaging of an infectious recombinant adeno-associated virus 2.
Gene therapy 1997;4(11):1167-72.
-
1997: Drake R R; McMasters R; Krisa S; Hume S D; Rechtin T M; Saylors R L; Chiang Y; Govindarajan R; Munshi N C
Metabolism and activities of 3'-azido-2',3'-dideoxythymidine and 2',3'-didehydro-2',3'-dideoxythymidine in herpesvirus thymidine kinase transduced T-lymphocytes.
Antiviral research 1997;35(3):177-85.
-
1997: Munshi N C; Tricot G J
Single weekly cytosine arabinoside and oral 6-thioguanine in patients with myelodysplastic syndrome and acute myeloid leukemia.
Annals of hematology 1997;74(3):111-5.
-
1997: Munshi N C
Immunoregulatory mechanisms in multiple myeloma.
Hematology/oncology clinics of North America 1997;11(1):51-69.
-
1997: Munshi N C; Govindarajan R; Drake R; Ding L M; Iyer R; Saylors R; Kornbluth J; Marcus S; Chiang Y; Ennist D; Kwak L; Reynolds C; Tricot G; Barlogie B
Thymidine kinase (TK) gene-transduced human lymphocytes can be highly purified, remain fully functional, and are killed efficiently with ganciclovir.
Blood 1997;89(4):1334-40.
-
1996: Ponnazhagan S; Wang X S; Woody M J; Luo F; Kang L Y; Nallari M L; Munshi N C; Zhou S Z; Srivastava A
Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infection.
The Journal of general virology 1996;77 ( Pt 6)():1111-22.
-
1995: Luo F; Zhou S Z; Cooper S; Munshi N C; Boswell H S; Broxmeyer H E; Srivastava A
Adeno-associated virus 2-mediated gene transfer and functional expression of the human granulocyte-macrophage colony-stimulating factor.
Experimental hematology 1995;23(12):1261-7.
-
1994: Munshi N C; Williams J R
Effect of tumor irradiation on the uptake of lymphokine-activated killer cells in a murine tumor model.
Cancer research 1994;54(7):1657-9.
-
1993: Munshi N C; Seitz D E; Fossella F; Lippman S M; Einhorn L H
Phase II study of sulofenur (LY 186641). A novel antineoplastic agent in advanced non-small cell lung cancer.
Investigational new drugs 1993;11(1):87-90.
-
1993: Munshi N C; Zhou S; Woody M J; Morgan D A; Srivastava A
Successful replication of parvovirus B19 in the human megakaryocytic leukemia cell line MB-02.
Journal of virology 1993;67(1):562-6.
-
1992: Srivastava C H; Zhou S; Munshi N C; Srivastava A
Parvovirus B19 replication in human umbilical cord blood cells.
Virology 1992;189(2):456-61.
-
1992: Munshi N C; Loehrer P J; Williams S D; Langefeld C; Sledge G; Nichols C R; Roth B J; Neuman A; Walsh W B; Einhorn L H
Comparison of N-acetylcysteine and mesna as uroprotectors with ifosfamide combination chemotherapy in refractory germ cell tumors.
Investigational new drugs 1992;10(3):159-63.
-
1991: Munshi N C; Loehrer P J; Williams S D
Uroprotection in patients receiving cyclophosphamide and ifosfamide.
Cancer treatment and research 1991;58():119-26.
-
1990: Munshi N C; Gabig T G
Growth factor-dependent initiation of DNA replication in nuclei isolated from an interleukin 3-dependent murine myeloid cell line.
The Journal of clinical investigation 1990;85(1):300-4.
Sign-in to see more
